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The genomes of bovine leukemia and human T-cell leukemia viruses both contain an unidentified region 
between the gag and pal genes. These regions harbor an open reading frame that is in a different phase 
from the reading frames of the gag and pol genes. Based on the deduced amino acid sequences, we show 
here that they potentially encode a gag precursor-cleaving protease, which is known to be fused to the gag 
and pal products of avian and murine retroviruses, respectively. This finding raises the interesting question 
of the expression and evolution of retroviral genes. 
Protease gene Retrovirus genome Sequence comparison 
1. INTRODUCTION 
Replication-competent retroviruses have only 3 
structural genes: the gag, pal and env genes, in this 
order [l]. The gag gene encodes core proteins, 
which are initially produced as a gag precursor 
polyprotein [2]. A protease that cleaves the gag 
precursor is encoded at the 3’ end of the gag gene 
of the Rous avian sarcoma virus (RSV) [2,3], and 
probably at the 5 ’ end of the pol gene of the 
Moloney murine leukemia virus (M-MuLV) [4]. 
Human T-cell leukemia virus (HTLV), causing 
adult T-cell leukemia [5,6], and bovine leukemia 
virus (BLV), causing enzootic bovine leukosis [7], 
are closely related [8,9] and their entire provial 
genomes have now been sequenced [lO,ll]. Cu- 
riously, however, no possible protease-coding 
regions have yet been identified in their genomic 
structures. We show here that these retroviruses do 
encode a protease but in an independent open 
reading frame between the gag and pol genes. 
lished nucleotide and deduced amino acid se- 
quences of BLV [ 111, HTLV [lo], M-MuLV [ 121 
and RSV [3]. The homology matrix comparisons 
and sequence alignments were performed as 
described [13,14]. 
3. RESULTS AND DISCUSSION 
2. MATERIALS AND METHODS 
For sequence comparisons, we used the pub- 
We have recently determined the complete 
nucleotide sequence of the proviral genome of 
BLV [9,11]. The genomic structures of the M- 
MuLV [12], RSV [3], HTLV [lo] and BLV [ll] 
proviruses are compared in fig.1. The BLV and 
HTLV genomes share a common structure: 5 ’ 
LTR-gag-intercistronic region_pol_env_pX(BL)-3 ’ 
LTR, where LTR represents a long terminal 
repeat, and OX an unidentified region. The 
presence of the pX(nrr sequences in these retro- 
viruses distinguishes them from the other retro- 
viruses ill]. Another remarkable feature of these 
retrovirus genomes is the existence of a very long 
intercistronic region (510 base pairs (bp) for BLV 
and 405 bp for HTLV) between the gag and pal 
genes; in M-MuLV and RSV, this intercistronic 
region is quite short (only a 3 bp amber stop codon 
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Fig.1. Comparison of the genomic structures of M- 
MuLV, RSV, HTLV and BLV. The genome of each 
virus is shown schematically in the proviral form (M- 
MuLV, RSV, HTLV and BLV from [12,3,10,11], 
respectively). The pX and pXnr in HTLV and BLV are 
unidentified regions. Domains of the putative M-MuLV 
protease (the N-terminal region of the pof gene) [4] and 
the RSV protease (the fifth gag protein) [2,3] are hatched 
and named P. See text and fig.2 for explanation of ORF- 
BL and ORF-HL. __ , LTR; m , gag gene; 
I, pal gene; C--. , em gene. 
for M-MuLV and 20 bp for RSV) (fig.1). In- 
terestingly, the BLV and HTLV intercistronic 
regions correspond closely to a (gag precursor- 
cleaving) protease-coding region of the M-MuLV 
and RSV genomes (see fig.1 legend). These obser- 
vations prompted us to examine whether the inter- 
cistronic regions represent as yet unidentified 
protease-coding genes of the BLV and HTLV 
genomes. 
Inspection of the nucleotide sequence around 
the gag-pol junction of the BLV genome reveals an 
open reading frame (designated as ORF-BL), span- 
ning nucleotides 1755-2258 and encoding 167 
amino acid residues (fig.2a). HTLV also contains 
an open reading frame (designated as ORF-HL) in 
the corresponding position (nucleotides 205 l-23 18), 
but encoding a much smaller protein of 88 amino 
acids (fig.2b). Neither ORF-BL nor ORF-HL 
opens with an initiator ATG codon, and the 5’ 
ends of both overlap the 3’ ends of the gag genes. 
These open reading frames are both in a different 
phase from the reading frames of the gag and pol 
genes. To assess whether ORF-BL and ORF-HL 
encode a protease, we initially compared their 
deduced amino acid sequences with those of the M- 
MuLV and RSV proteases by a 2-dimensional 
homology matrix [13], finding partial but signifi- 
cant homologies between them (not shown). Based 
on this finding, we aligned the 4 sequences with 
minimal gaps to maximize the homology [ 141. This 
gave the result in fig.3a, where the M-MuLV se- 
quence is derived from the N-terminal 1 lo-residue 
sequence (putative protease domain) of the pal 
product [4,12], while the RSV sequence includes, 
besides the fifth gag protein (~15) as a protease, a 
C-terminal 18-residue sequence of the fourth gag 
protein (~12) [2,3], because this has appreciable 
homology with the N-terminal regions of the other 
a BLV 
Ii? ORF-BL rgSerQhe?roLeuGluThrArgCeuSerAsnProGln~teLysLysLeu~leGluGtyGlyLeuSerAlaProGlnThrl~eThrProIleThrAspSerLeuSerGluAlaGluLeUGl~ySLeUL~US~~ 
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CyrProIleCysLysAspProSerHisTrpLysArgAspCysP~ThrLeuLysSerL sAsn l * 
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' 1890 
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TCCCCCCCGCAGTGCTCGA~~GTCTCCCCGCAGATAC~TT~CTAC~~CCTCTGACCCT~CTCT~CCAGAffiGTCCCTTlATCACCATCCCA~TTTTAGTTGACACTTCCGAC~ATG~~TtttAG 
. . . . 2(go 
Fig.2. Nucleotide and deduced amino acid sequences of the open reading frames found arround the gag-poi junctions 
of the (a) BLV and (b) HTLV genomes. In both BLV [ I1 ] and HTLV [lo], a 600 bp sequence spanning the gag-pal 
junction is presented. (a) ORF-BL and (b) ORF-HL represent open reading frames. Arrowed underlines denote palin- 
dromic sequences. 
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Fig.3. Amino acid sequence homologies between ORF-BL, ORF-HL and proteases of M-MuLV and RSV (a) and open 
reading frames encoding the possible C-terminal half of the putative HTLV protease (b). (a) Amino acid residues are 
expressed as one-letter codes. The BLV (ORF-BL) and HTLV (ORF-HL) sequences are from fig.2. The M-MuLV se- 
quence is derived from an N-terminal 1 lo-residue sequence of the pol gene [12], which probably represents a I3-kDa 
protease [4]. The RSV sequence includes a C-terminal l&residue sequence of the fourth gag protein (~12) immediately 
preceding the protease (the fifth gag protein, 15 kDa) [2,3]. Conserved residues are boxed and highly conserved regions 
and marked I, II, III and IV. (b) Other open reading frames that could encode a possible C-terminal half of the putative 
HTLV protease. ORF-2 is separated from ORF-1 by a single amber stop codon. Assuming this stop codon is read 
through, the deduced amino acid sequence can be aligned with the C-terminal half of the ORF-BL sequence (positions 
89-175 in (a)) without any gaps, and matched residues are boxed. 
viral sequences. The overall homologies (counting 
gaps) between the sequence of ORF-BL and those 
of the M-MuLV and RSV proteases reach 25%. 
Moreover, there are 4 highly conserved regions in 
the 3 sequences (marked I, II, III and IV in fig.3a), 
each as long as 4-7 amino acid residues and located 
30-50 residues from each other. Thus, the facts 
that ORF-BL is located at a position correspon- 
ding to the protease-coding regions of the M- 
MuLV and RSV genomes (fig.1) and that its 
deduced amino acid sequence bears appreciable 
homology with both protease sequences (fig.3a) 
strongly suggest hat ORF-BL encodes a BLV pro- 
tease. The amino acid sequence of ORF-HL is only 
about half as long as those of the ORF-BL and M- 
MuLV and RSV proteases and can be aligned with 
only their N-terminal &residue sequences (fig. 
3a). It shows the highest homology (29%) with the 
putative BLV protease (ORF-BL), reflecting the 
closest relationship of HTLV with BLV [ll], and 
also contains well conserved sequences (regions I 
and II). Thus it presumably represents an HTLV 
protease, in spite of its small size, 
The apparent lack of a C-terminal 70-residue se- 
quence in the putative HTLV protease is curious, 
because in the other viral proteases uch sequences 
commonly contain well conserved sequences 
(regions III and IV, fig.3a). Further inspection of 
the HTLV sequence around and downstream of 
the ORF-HL revealed two more open reading 
frames, ORF-1 (nucleotides 2291-2437; fig.3b) 
and ORF-2 (nucleotides 2441-2752). The 5 ’ end of 
ORF-1 overlaps the 3’ end of ORF-HL, and 
ORF-2 is separated from ORF-1 by a single amber 
stop codon and ends with the 259th nucleotide of 
the pal gene. Surprisingly, these open reading 
frames contain two amino acid sequences (Gly- 
Ala-Gly-Gly in ORF- 1 and Ile-Ile-Gly-Arg-Asp in 
ORF-2) that are homologous with the well con- 
served sequences (regions III and IV, respectively, 
in fig.3a) of the C-terminal halves of the other pro- 
teases. Remarkably, sequence alignment with the 
C-terminal half of the putative BLV protease can be 
performed without any gaps and reveals 3 highly 
homologous regions (two of these correspond to the 
above-mentioned conserved sequences), as shown 
by the boxed residues in fig.3b. Thus, we suggest 
that ORF-1 and ORF-2 together represent he C- 
terminal half of the putative HTLV protease, 
although they are separated by a single stop codon. 
At present, we do not know the actual N- and C- 
termini of the putative BLV and HTLV proteases, 
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nor do we know how their genes are transcribed 
and translated. However, the BLV protease is 
possibly produced as a gag-protease polyprotein 
because BLV mRNA produces a 70-kDa polypro- 
tein that contains, besides a 45kDa gag precursor, 
an additional but unknown polypeptide [7,15,16], 
which can be assumed to be a protease. If so, the 
mRNA for the polyprotein might be generated by 
such splicing as removes the stop codon between, 
and causes the in-frame fusion of, the gag and pro- 
tease genes. Regarding this, we note that both BLV 
and HTLV harbor a palindromic structure around 
the gag-protease junction (see arrowed underlines 
in fig.2); such a palindromic structure may be in- 
volved in the possible splicing events [17]. The 
BLV protease may also be generated as a 145kDa 
polyprotein (a putative gag-p01 precursor [ 15]), 
since this molecule contains all the tryptic peptides 
of the 70-kDa polyprotein [7]. 
The present observations raise the interesting 
question of how organization of the protease gene 
and its surrounding genes has changed during 
retrovirus evolution. Roughly speaking, two 
models seems to be possible. One is that the 
primordial retrovirus had a single gene for gag- 
protease-pal and that during evolution this under- 
went mutation, resulting in a stop codon at 
either or both ends of the protease-coding region, 
thereby producing a gag-fused (for RSV), pol- 
fused (for M-MuLV) or independent (for BLV and 
HTLV) protease gene. This model assumes the ex- 
istence of a single gene of unusually enormous size 
and requires at least two steps to generate the in- 
dependent protease gene of BLV or HTLV. The 
other simpler model that we favour is that the 
primordial retrovirus had 3 independent gag, pro- 
tease and pol genes, like the present BLV (or 
HTLV). In this case, only a single step mutation, 
to abolish a stop codon and to cause a frameshift, 
between either the gag and protease genes or the 
protease and pol genes would generate a gag-fused 
(for RSV) or pal-fused (for M-MuLV) protease 
gene. This model is consistent with the protovirus 
hypothesis [18]. Further analysis of the genomic 
structures of other types of viruses would shed 
light on this problem. 
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